- TD-6450: Phase 2a study in hepatitis C virus (HCV) (2016)
Catalyst
Slingshot members are tracking this event:
Phase 2a of TD-6450 for Hepatitis C virus due 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TBPH | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 29, 2017
Occurred Source:
https://clinicaltrials.gov/archive/NCT02593162/2017_01_29/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2a, Td-6450, Hepatitis C Virus, Hcv
